CEMIP and gastric cancer: Our finding of high tumor CEMIP expression associated with poor prognosis in colon cancer is supported by findings of a 50% decrease in 5-year survival of gastric cancer patients whose tumors expressed high versus low CEMIP [35] as well as a survey of breast cancer DNA microarray datasets finding reduced survival in patients with tumors expressing high versus low CEMIP [36].